World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Yang ZL, Wang HK, Liu Y, Dou LZ, Zhang YM, Ng HI, He S, Chi YB, Wang GQ. Progression after endoscopic treatment for type I gastric neuroendocrine tumors: A single-center retrospective study. World J Gastroenterol 2026; 32(8): 114268 [PMID: 41809874 DOI: 10.3748/wjg.v32.i8.114268]
URL:	https://www.wjgnet.com/1007-9327/full/v32/i8/114268.htm

(52) (91) (0) (0) (0) (19) (1) (1) (1084) (1)

Number	Citing Articles
1	Bengi Ozturk, Hatime Arzu Yasar. Letter to the Editor: Reconsidering the routine use of adjuvant somatostatin analogs in type I gastric neuroendocrine tumors after endoscopic treatment. World Journal of Gastroenterology 2026; 32(36): 120316 doi: 10.3748/wjg.120316 Abstract(33) \| Core Tip(42) \| Full Article(HTML)(128) \| Full Article (PDF)-340K(13) \| Full Article with Cover (PDF)-772K(8) \| Full Article (XML)-30K(10) \| Audio-487K(1) \| Peer-Review Report-248K(18) \| Answering Reviewers-61K(16) \| Times Cited (0) \| Total Visits (159) \| Open

Number

Citing Articles

Bengi Ozturk, Hatime Arzu Yasar. Letter to the Editor: Reconsidering the routine use of adjuvant somatostatin analogs in type I gastric neuroendocrine tumors after endoscopic treatment. World Journal of Gastroenterology 2026; 32(36): 120316 doi: 10.3748/wjg.120316

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.